University of Massachusetts

Worcester, Massachusetts, United States
Purpose
to test the idea of delivering small interfering RNA (siRNAs) via glucan particles in an oral TB vaccine formulation. The team will utilize the siRNAs’ ability to block immunosuppressive signaling and amplify the immune response.
Grantee
Division
Global Health
Date
NOVEMBER 2009
Region served
GLOBAL
Committed amount
$100,000
Grant topic
Discovery and Translational Sciences
Duration (months)
18
Grantee location
Worcester, Massachusetts, United States
Related work

More about our financials

Our story

Learn about the origins of the foundation and the values that drive our work.

Our work

Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.

How we work

We are focused on results. Those that can be measured. And those measured in ways beyond numbers.